Jeevan Scientific Technology Limited
BSE: JSTL
Prev Close
66.63
Open Price
67.1
Volume
10,415
Today Low / High
63.3 / 68.98
52 WK Low / High
32.85 / 76.99
Range
61 - 67
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 63.91, reflecting a change of -2.72 (-4.08225%). The expected target range on the BSE is 61 - 67. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Jeevan Scientific Technology Limited Graph
Jeevan Scientific Technology Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Jeevan Scientific Technology Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 63.91, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 63.91 | 64.55 | 58.09 - 71.00 |
| 65.19 | 52.15 - 78.23 | ||
| 65.83 | 46.08 - 85.58 | ||
| Bearish Scenario | 63.91 | 63.27 | 56.94 - 69.60 |
| 62.63 | 50.11 - 75.16 | ||
| 61.99 | 43.39 - 80.59 |
Overview of Jeevan Scientific Technology Limited
ISIN
INE237B01018
Industry
Medical - Care Facilities
Vol.Avg
16,283
Market Cap
1,115,030,280
Last Dividend
0
Official Website
IPO Date
2024-12-30
DCF Diff
141.79
DCF
-71
Financial Ratios Every Investor Needs
Stock Dividend of JSTL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-09-21 | September 21, 22 | 1.2 | 1.2 | 2022-09-22 | 2022-10-29 | |
| 2021-09-07 | September 07, 21 | 0.5 | 0.5 | 2021-09-08 | 2021-10-15 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 46.84 Cr | 3.80 Cr | 43.04 Cr | 0.9188 | 0.00 Cr | 17.08 Cr | 1.16 Cr | 0.13 Cr | 0.08 | 8.06 Cr | 0.0029 |
| 2024-03-31 | 39.65 Cr | 25.30 Cr | 14.35 Cr | 0.3618 | 0.00 Cr | 3.06 Cr | -1.24 Cr | -1.30 Cr | -0.84 | 5.29 Cr | -0.0327 |
| 2023-03-31 | 36.18 Cr | 3.00 Cr | 33.18 Cr | 0.9170 | 0.00 Cr | 2.38 Cr | -3.62 Cr | -3.05 Cr | -1.99 | 2.41 Cr | -0.0843 |
| 2022-03-31 | 67.79 Cr | 7.39 Cr | 60.40 Cr | 0.8909 | 0.00 Cr | 9.13 Cr | 13.14 Cr | 11.94 Cr | 7.81 | 22.68 Cr | 0.1762 |
| 2021-03-31 | 47.48 Cr | 0.64 Cr | 46.84 Cr | 0.9865 | 0.00 Cr | 4.63 Cr | 14.06 Cr | 11.74 Cr | 7.67 | 19.82 Cr | 0.2473 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.24 Cr | 78.29 Cr | 28.22 Cr | 49.9437 Cr | 20.58 Cr | 20.34 Cr | 1.62 Cr | 32.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 12.0705 Cr |
| 2024-03-31 | 0.54 Cr | 67.87 Cr | 19.23 Cr | 48.4284 Cr | 13.41 Cr | 12.87 Cr | 1.09 Cr | 36.02 Cr | 0.54 Cr | 0.00 Cr | 0.00 Cr | 9.2080 Cr |
| 2023-03-31 | 6.83 Cr | 65.92 Cr | 17.50 Cr | 48.1896 Cr | 10.10 Cr | 3.26 Cr | 0.87 Cr | 29.42 Cr | 1.09 Cr | 0.00 Cr | -4.64 Cr | 11.3895 Cr |
| 2022-03-31 | 29.71 Cr | 77.88 Cr | 27.30 Cr | 50.5831 Cr | 12.54 Cr | -17.17 Cr | 1.46 Cr | 18.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 22.2948 Cr |
| 2021-03-31 | 3.26 Cr | 65.98 Cr | 30.95 Cr | 35.0228 Cr | 10.35 Cr | 7.09 Cr | 3.46 Cr | 15.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 22.8648 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 10.0729 Cr | -15.6199 Cr | 5.2448 Cr | -5.9585 Cr | -0.3022 Cr | 0.2423 Cr | -16.0314 Cr | 0.0507 Cr | 4.3608 Cr | 0.0000 Cr | -0.5283 Cr |
| 2024-03-31 | 2.8919 Cr | -11.5276 Cr | 2.3464 Cr | -9.1371 Cr | -6.2893 Cr | 0.5445 Cr | -12.0290 Cr | -1.6039 Cr | 4.3423 Cr | 0.0000 Cr | -0.2183 Cr |
| 2023-03-31 | -6.4052 Cr | -6.9309 Cr | -9.5435 Cr | -14.5680 Cr | -22.8795 Cr | 6.8338 Cr | -8.1628 Cr | -3.6827 Cr | -6.1037 Cr | -1.8362 Cr | 0.5840 Cr |
| 2022-03-31 | 19.5614 Cr | -1.2044 Cr | 5.6716 Cr | 17.2191 Cr | 24.0285 Cr | 29.7133 Cr | -2.3423 Cr | 18.3489 Cr | -3.3975 Cr | -0.7651 Cr | 3.4881 Cr |
| 2021-03-31 | 4.9471 Cr | -0.7990 Cr | -0.1328 Cr | 4.1481 Cr | 4.0153 Cr | 6.2115 Cr | -0.7990 Cr | 13.6496 Cr | -0.1328 Cr | 0.0000 Cr | -2.5090 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 19.07 Cr | 8.64 Cr | 10.43 Cr | 0.5471 | 3.63 Cr | 1.42 Cr | 0.90 | 5.23 Cr | 0.0746 |
| 2025-09-30 | 12.38 Cr | 7.79 Cr | 4.59 Cr | 0.3705 | 0.38 Cr | -0.09 Cr | -0.06 | 2.27 Cr | -0.0071 |
| 2025-06-30 | 8.80 Cr | 0.77 Cr | 8.03 Cr | 0.9121 | -3.53 Cr | -3.10 Cr | -2.03 | -1.45 Cr | -0.3525 |
| 2025-03-31 | 10.06 Cr | 1.15 Cr | 8.90 Cr | 0.8853 | -2.15 Cr | -1.30 Cr | -0.82 | -0.24 Cr | -0.1292 |
| 2024-12-31 | 12.51 Cr | 0.85 Cr | 11.65 Cr | 0.9318 | 0.60 Cr | 0.11 Cr | 0.07 | 2.30 Cr | 0.0084 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.78 Cr | 1.57 Cr | 2.35 Cr | 17.10 Cr | 2.32 Cr | 32.72 Cr | 29.64 Cr | 83.81 Cr | 36.59 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -50.07 Cr |
| 2025-03-31 | 0.24 Cr | 1.55 Cr | 1.79 Cr | 15.94 Cr | 1.62 Cr | 28.76 Cr | 32.39 Cr | 78.29 Cr | 28.22 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -50.25 Cr |
| 2024-09-30 | 2.56 Cr | 1.55 Cr | 4.11 Cr | 13.72 Cr | 1.35 Cr | 26.40 Cr | 27.81 Cr | 73.14 Cr | 22.89 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -3.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -1.30 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,803.00 | ₹1,121,951,678,571.00 | ₹381,240.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,043.10 | ₹1,015,033,073,603.00 | ₹2,366,853.00 |
| Fortis Healthcare Limited | FORTIS | ₹881.80 | ₹665,722,094,906.00 | ₹867,525.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,750.50 | ₹355,526,261,168.00 | ₹315,853.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹665.50 | ₹344,021,264,708.00 | ₹341,357.00 |
| Global Health Limited | MEDANTA | ₹1,105.20 | ₹297,067,116,924.00 | ₹75,686.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹688.50 | ₹275,495,656,748.00 | ₹528,722.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,183.20 | ₹120,164,798,112.00 | ₹125,027.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,264.90 | ₹82,934,461,228.00 | ₹7,476.00 |
| HealthCare Global Enterprises Limited | HCG | ₹578.50 | ₹82,077,101,002.00 | ₹120,568.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹681.40 | ₹65,655,858,860.00 | ₹286,244.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹404.10 | ₹37,045,059,300.00 | ₹165,521.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹229.81 | ₹36,192,560,189.00 | ₹51,585.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1960
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1977
Gender: male
Year Born:
Gender: male
Year Born: 1972
Gender: female
Year Born: 1992
FAQs about Jeevan Scientific Technology Limited
The CEO is Srinivas Reddy Maram.
The current price is ₹70.42.
The range is ₹32.85-76.99.
The market capitalization is ₹111.50 crores.
The P/E ratio is -36.38.
The company operates in the Healthcare sector.
Overview of Jeevan Scientific Technology Limited (ISIN: INE237B01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹111.50 crores and an average daily volume of 16,283 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.